Bayan Hussein Sajer
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Bayan Hussein Sajer has a total of 77 co-authors. Here are the top co-authors by number of shared publications:
- Faisal Al-Sarraj
Department of Biological Sciences, Faculty of Science, King Abdulaziz University, Jeddah 21589, Saudi Arabia
4 shared publications - Ibrahim Alotibi
Health Information Technology Department, The Applied College, King Abdulaziz University, Jeddah 21589, Saudi Arabia
3 shared publications - Majid Al-Zahrani
Department of Biological Sciences, College of Sciences and Art, King Abdulaziz University, Rabigh, Saudi Arabia
3 shared publications - Mashail A. Alghamdi
Department of Biological Sciences, Faculty of Science, King Abdulaziz University, Jeddah 21589, Saudi Arabia
3 shared publications - Nada Mahmoud Nass
Department of Biological Sciences, Faculty of Science, King Abdulaziz University, Jeddah 21589, Saudi Arabia
3 shared publications - Alya Redhwan
Department of Health, College of Health and Rehabilitation Sciences, Princess Nourah bint Abdulrahman University, Riyadh, Saudi Arabia
2 shared publications
Latest Publications
- 20 November 2025
- Published by Springer Nature in Chemical Papers
- Vol. 80 (1) , 245-261
Overcoming antifungal drug resistance: potent antioxidant, antifungal, genotoxic, and antibiofilm properties of Lavandula angustifolia and Thymus vulgaris against candida species
- 20 November 2025
- Published by Springer Nature in Chemical Papers
- Vol. 80 (1) , 245-261
Overcoming antifungal drug resistance: potent antioxidant, antifungal, genotoxic, and antibiofilm properties of Lavandula angustifolia and Thymus vulgaris against candida species
- Open Access
- 28 July 2025
- Published by Egyptian Knowledge Bank in Egyptian Journal of Veterinary Sciences
- p. 1-17
Molecular Docking and Dynamics Simulations for In -Silico Evaluation of 2,4-Di-tert-butylphenol (2,4-DTBP) as a Potential Breast Cancer Inhibitor
Breast cancer (BC) is still one of the major causes of death in females, mainly because of the uncontrollable proliferation of breast cells. In this study, we analyzed the potency of 2,4-Di-tert-butylphenol (2,4-DTBP), a natural compound, against cancer through computer programs like molecular docking and molecular dynamics (MD) simulations. Molecular docking was conducted with AutoDockTool to evaluate 2,4-DTBP's interaction with critical breast cancer proteins, specifically PIK3CA, ESR1, and PTEN. Binding affinities (kcal/mol) and inhibition constants were evaluated to determine notable protein-ligand interactions. Molecular dynamics (MD) simulations were performed using the CABS-flex webserver to assess the stability of these interactions via RMSF and binding free energy analyses. The study utilized multiple methodologies, including PASS prediction, ADME assessment, toxicity profiling, Lipinski’s Rule of Five, and evaluation of anticancer activity. Strong binding affinities of 2,4-DTBP towards important breast cancer proteins were found by the docking results; the binding energy values ranged from -5.25 to -7.86 kcal/mol. Meaningful binding energies of -7.86, -7.68, and -7.36 kcal/mol have been detected for PIK3CA, ESR1, and PTEN, respectively. Protein-ligand complex stability was validated by molecular dynamics simulations, and PTEN exhibited the most stable association because of its higher structural stiffness and lower RMSF values. The 2,4-DTBP demonstrated acceptable standards in every evaluated metric. According to the in-silico results, 2,4-DTBP exhibits encouraging potential as a strong inhibitor of significant breast cancer targets, specifically PTEN, PIK3CA, and ESR1, which calls for additional in-vitro and in-vivo studies to further investigate its efficacy in treating cancer.
- 28 July 2025
- Published by Egyptian Knowledge Bank in Egyptian Journal of Veterinary Sciences
- p. 1-17
Open AccessMolecular Docking and Dynamics Simulations for In -Silico Evaluation of 2,4-Di-tert-butylphenol (2,4-DTBP) as a Potential Breast Cancer Inhibitor
Breast cancer (BC) is still one of the major causes of death in females, mainly because of the uncontrollable proliferation of breast cells. In this study, we analyzed the potency of 2,4-Di-tert-butylphenol (2,4-DTBP), a natural compound, against cancer through computer programs like molecular docking and molecular dynamics (MD) simulations. Molecular docking was conducted with AutoDockTool to evaluate 2,4-DTBP's interaction with critical breast cancer proteins, specifically PIK3CA, ESR1, and PTEN. Binding affinities (kcal/mol) and inhibition constants were evaluated to determine notable protein-ligand interactions. Molecular dynamics (MD) simulations were performed using the CABS-flex webserver to assess the stability of these interactions via RMSF and binding free energy analyses. The study utilized multiple methodologies, including PASS prediction, ADME assessment, toxicity profiling, Lipinski’s Rule of Five, and evaluation of anticancer activity. Strong binding affinities of 2,4-DTBP towards important breast cancer proteins were found by the docking results; the binding energy values ranged from -5.25 to -7.86 kcal/mol. Meaningful binding energies of -7.86, -7.68, and -7.36 kcal/mol have been detected for PIK3CA, ESR1, and PTEN, respectively. Protein-ligand complex stability was validated by molecular dynamics simulations, and PTEN exhibited the most stable association because of its higher structural stiffness and lower RMSF values. The 2,4-DTBP demonstrated acceptable standards in every evaluated metric. According to the in-silico results, 2,4-DTBP exhibits encouraging potential as a strong inhibitor of significant breast cancer targets, specifically PTEN, PIK3CA, and ESR1, which calls for additional in-vitro and in-vivo studies to further investigate its efficacy in treating cancer.
- Open Access
- 6 August 2024
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 25 (16) , 8570
Genetic Patterns of Oral Cavity Microbiome in Patients with Sickle Cell Disease
The Middle Eastern prevalence of sickle cell anemia, a genetic disorder that affects red blood cells, necessitates additional research. On a molecular level, we sought to identify and sort the oral microbiota of healthy individuals and those with sickle cell anemia. Furthermore, it is crucial to comprehend how changes in the genetic makeup of the oral microbiota impact the state of sickle cell anemia. Using next-generation sequencing, the 16S rRNA amplicon was examined using saliva samples from 36 individuals with sickle cell anemia and healthy individuals. These samples were obtained from sickle cell anemia patients (18 samples) and healthy control participants (controls, 18 samples). Various analyses are conducted using bioinformatic techniques to identify distinct species and their relative abundance. Streptococcus, followed by Fusobacterium nucleatum, Prevotella, and Veillonella were the most prevalent genera of bacteria in the saliva of the SCA and non-SCA individuals according to our findings. Rothia mucilaginosa, Prevotella scoposa, and Veillonella dispar species were the dominant species in both sickle cell anemia and non-sickle cell anemia subjects. Streptococcus salivarius, Actinomyces graevenitzii, Actinomyces odontolyticus, and Actinomyces georgiae spp. were the most prevalent bacterial spp. in the studied SCA cases. The sequencing of the 16S rRNA gene yielded relative abundance values that were visualized through a heatmap analysis. Alterations in the oral microflora’s constitution can significantly affect the susceptibility of sickle cell anemia patients to develop more severe health complications. Salivary diagnosis is a potential tool for predicting and preventing oral microbiome-related diseases in the future.
- 6 August 2024
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 25 (16) , 8570
Open AccessGenetic Patterns of Oral Cavity Microbiome in Patients with Sickle Cell Disease
The Middle Eastern prevalence of sickle cell anemia, a genetic disorder that affects red blood cells, necessitates additional research. On a molecular level, we sought to identify and sort the oral microbiota of healthy individuals and those with sickle cell anemia. Furthermore, it is crucial to comprehend how changes in the genetic makeup of the oral microbiota impact the state of sickle cell anemia. Using next-generation sequencing, the 16S rRNA amplicon was examined using saliva samples from 36 individuals with sickle cell anemia and healthy individuals. These samples were obtained from sickle cell anemia patients (18 samples) and healthy control participants (controls, 18 samples). Various analyses are conducted using bioinformatic techniques to identify distinct species and their relative abundance. Streptococcus, followed by Fusobacterium nucleatum, Prevotella, and Veillonella were the most prevalent genera of bacteria in the saliva of the SCA and non-SCA individuals according to our findings. Rothia mucilaginosa, Prevotella scoposa, and Veillonella dispar species were the dominant species in both sickle cell anemia and non-sickle cell anemia subjects. Streptococcus salivarius, Actinomyces graevenitzii, Actinomyces odontolyticus, and Actinomyces georgiae spp. were the most prevalent bacterial spp. in the studied SCA cases. The sequencing of the 16S rRNA gene yielded relative abundance values that were visualized through a heatmap analysis. Alterations in the oral microflora’s constitution can significantly affect the susceptibility of sickle cell anemia patients to develop more severe health complications. Salivary diagnosis is a potential tool for predicting and preventing oral microbiome-related diseases in the future.
- Open Access
- 1 August 2024
- Published by Taylor & Francis in Biologics: Targets and Therapy
- Vol. ume 18, 207-228
Aspergillus Species from the Sabkha Marsh: Potential Antimicrobial and Anticancer Agents Revealed Through Molecular and Pharmacological Analysis
Introduction: This study aimed to investigate the fungal growth and diversity in the Sabkha marsh. The anti-bacterial properties of the isolated fungi were assessed using an agar disk diffusion assay, and the crude extracts were tested for their anticancer activities. Liquid chromatography-mass spectrometry was employed to identify the active compounds of the fungal secondary metabolites. In-silico studies were conducted to predict the toxicity, pharmacokinetic properties, and safety profiles of the identified compounds. Results: The analysis revealed that the isolated fungi belonged to the Aspergillus species, specifically Aspergillus flavus and Aspergillus niger. The crude extract of A. flavus exhibited significant anticancer activity against various cancer cell lines, while the antifungal activities against pathogenic bacteria varied between the two fungi. Liquid chromatography-mass spectrometry analysis identified several compounds in the fungal isolates. In Aspergillus flavus, the compounds included Aflavinine, Dihydro-24-hydroxyaflavinine, Phomaligin A, Hydroxysydonic acid, Gregatin B, Pulvinulin A, Chrysogine, Aspergillic acid, Aflatoxin B1, and Aflatoxin G1. In Aspergillus niger, the compounds identified were atromentin, fonsecin B, firalenone, rubrofusarin, aurasperone E, aurasperone D, aurasperone C, nigerone, and αβ-dehydrocurvularin. Conclusion: This study demonstrated promising fungal growth and diversity in the Sabkha marsh, with Aspergillus species being the most prevalent. The fungal crude extract showed anticancer activities against various cancer cell lines, while the antifungal activities against pathogenic bacteria varied between the two fungi. Future research should focus on investigating the antimicrobial activities of these fungi against multidrug-resistant bacteria and exploring the genetic changes in bacteria and cancer cells treated with these fungal extracts. Additionally, it is important to test the anticancer activity of the active compounds separately to determine which one is the active agent against cancer cells. This information can be used in drug development trials.
- 1 August 2024
- Published by Taylor & Francis in Biologics: Targets and Therapy
- Vol. ume 18, 207-228
Open AccessAspergillus Species from the Sabkha Marsh: Potential Antimicrobial and Anticancer Agents Revealed Through Molecular and Pharmacological Analysis
Introduction: This study aimed to investigate the fungal growth and diversity in the Sabkha marsh. The anti-bacterial properties of the isolated fungi were assessed using an agar disk diffusion assay, and the crude extracts were tested for their anticancer activities. Liquid chromatography-mass spectrometry was employed to identify the active compounds of the fungal secondary metabolites. In-silico studies were conducted to predict the toxicity, pharmacokinetic properties, and safety profiles of the identified compounds. Results: The analysis revealed that the isolated fungi belonged to the Aspergillus species, specifically Aspergillus flavus and Aspergillus niger. The crude extract of A. flavus exhibited significant anticancer activity against various cancer cell lines, while the antifungal activities against pathogenic bacteria varied between the two fungi. Liquid chromatography-mass spectrometry analysis identified several compounds in the fungal isolates. In Aspergillus flavus, the compounds included Aflavinine, Dihydro-24-hydroxyaflavinine, Phomaligin A, Hydroxysydonic acid, Gregatin B, Pulvinulin A, Chrysogine, Aspergillic acid, Aflatoxin B1, and Aflatoxin G1. In Aspergillus niger, the compounds identified were atromentin, fonsecin B, firalenone, rubrofusarin, aurasperone E, aurasperone D, aurasperone C, nigerone, and αβ-dehydrocurvularin. Conclusion: This study demonstrated promising fungal growth and diversity in the Sabkha marsh, with Aspergillus species being the most prevalent. The fungal crude extract showed anticancer activities against various cancer cell lines, while the antifungal activities against pathogenic bacteria varied between the two fungi. Future research should focus on investigating the antimicrobial activities of these fungi against multidrug-resistant bacteria and exploring the genetic changes in bacteria and cancer cells treated with these fungal extracts. Additionally, it is important to test the anticancer activity of the active compounds separately to determine which one is the active agent against cancer cells. This information can be used in drug development trials.
- Open Access
- 26 December 2023
- Published by Naba'a Al-Hayat Foundation for Medical Sciences and Health Care in Journal of Contemporary Medical Sciences
- Vol. 9 (6) , 420-430
Extract of microbial isolates from the western region of the Kingdom of Saudi Arabia and their applications in the field of health
Objectives: In a previous study, the presence of Aspergillus species in high-salt soil was investigated. However, it was hypothesized that the addition of a protein source to the soil could reveal other fungal species. This study aimed to test this hypothesis by repeating the methodology used in the previous study, but with the inclusion of a protein source. Methods: The ribosomal DNA (ITS) region was sequenced to identify the fungal isolate. The results showed that the isolate belonged to a different genus within the Aspergillus species, specifically Aspergillus sydowii. The strain was named WIS and recorded in the gene bank with the accession number OR262340.1. The antibacterial activity of the isolated fungus was evaluated by measuring the inhibition zone diameter after exposing pathogenic bacteria to the fungus. Additionally, the anti-cancer activity of the isolate was tested on six different cell lines, including breast cancer, hepatic cancer, and colorectal cancer. To further support the evidence of the bioactivity of this fungus, liquid chromatography-mass spectrometry (LCMS) was conducted on the fungal extract to identify its secondary medicinal metabolites. Additionally, an in-silico study was performed to predict the toxicity, pharmacokinetic properties, and safety profiles of each molecule. Results: Aspergillus sydowii exhibited antibacterial activity against both gram-positive and gram-negative bacteria. It also demonstrated excellent anti-cancer activity on all tested cell lines. Conclusion: Future studies should focus on investigating the antimicrobial activities of this fungus against a wider range of pathogenic bacteria, particularly multidrug-resistant strains. Furthermore, it would be beneficial to study the genetic changes in bacteria and cancer cells treated with these fungal extracts at the genetic level.
- 26 December 2023
- Published by Naba'a Al-Hayat Foundation for Medical Sciences and Health Care in Journal of Contemporary Medical Sciences
- Vol. 9 (6) , 420-430
Open AccessExtract of microbial isolates from the western region of the Kingdom of Saudi Arabia and their applications in the field of health
Objectives: In a previous study, the presence of Aspergillus species in high-salt soil was investigated. However, it was hypothesized that the addition of a protein source to the soil could reveal other fungal species. This study aimed to test this hypothesis by repeating the methodology used in the previous study, but with the inclusion of a protein source. Methods: The ribosomal DNA (ITS) region was sequenced to identify the fungal isolate. The results showed that the isolate belonged to a different genus within the Aspergillus species, specifically Aspergillus sydowii. The strain was named WIS and recorded in the gene bank with the accession number OR262340.1. The antibacterial activity of the isolated fungus was evaluated by measuring the inhibition zone diameter after exposing pathogenic bacteria to the fungus. Additionally, the anti-cancer activity of the isolate was tested on six different cell lines, including breast cancer, hepatic cancer, and colorectal cancer. To further support the evidence of the bioactivity of this fungus, liquid chromatography-mass spectrometry (LCMS) was conducted on the fungal extract to identify its secondary medicinal metabolites. Additionally, an in-silico study was performed to predict the toxicity, pharmacokinetic properties, and safety profiles of each molecule. Results: Aspergillus sydowii exhibited antibacterial activity against both gram-positive and gram-negative bacteria. It also demonstrated excellent anti-cancer activity on all tested cell lines. Conclusion: Future studies should focus on investigating the antimicrobial activities of this fungus against a wider range of pathogenic bacteria, particularly multidrug-resistant strains. Furthermore, it would be beneficial to study the genetic changes in bacteria and cancer cells treated with these fungal extracts at the genetic level.
- Open Access
Green Synthesis of Chitosan-Capped Gold Nanoparticles Using Salvia officinalis Extract: Biochemical Characterization and Antimicrobial and Cytotoxic Activities
Increasing antimicrobial resistance to the action of existing antibiotics has prompted researchers to identify new natural molecules with antimicrobial potential. In this study, a green system was developed for biosynthesizing gold nanoparticles (BAuNPs) using sage (Salvia officinalis L.) leaf extract bioconjugated with non-toxic, eco-friendly, and biodegradable chitosan, forming chitosan/gold bioconjugates (Chi/BAuNPs). Characterization of the BAuNPs and Chi/BAuNPs conjugates takes place using transmission electron microscopy (TEM), X-ray spectra, Fourier transform infrared (FT-IR) spectroscopy, and zeta potential (Z-potential). The chemical composition of S. officinalis extract was evaluated via gas chromatography/mass spectrometry (GC/MS). This study evaluated the antioxidant and antimicrobial activities of human pathogenic multidrug-resistant (MDR) and multisensitive (MS) bacterial isolates using the agar diffusion method. Chi/BAuNPs showed inhibition of the MDR strains more effectively than BAuNPs alone as compared with a positive standard antibiotic. The cytotoxicity assay revealed that the human breast adenocarcinoma cancer cells (MCF7) were more sensitive toward the toxicity of 5-Fu + BAuNPs and 5-Fu + Chi/BAuNPs composites compared to non-malignant human fibroblast cells (HFs). The study shows that BAuNPs and Chi/BAuNPs, combined with 5-FU NPs, can effectively treat cancer at concentrations where the free chemical drug (5-Fu) is ineffective, with a noted reduction in the required dosage for noticeable antitumor action.
Open AccessGreen Synthesis of Chitosan-Capped Gold Nanoparticles Using Salvia officinalis Extract: Biochemical Characterization and Antimicrobial and Cytotoxic Activities
Increasing antimicrobial resistance to the action of existing antibiotics has prompted researchers to identify new natural molecules with antimicrobial potential. In this study, a green system was developed for biosynthesizing gold nanoparticles (BAuNPs) using sage (Salvia officinalis L.) leaf extract bioconjugated with non-toxic, eco-friendly, and biodegradable chitosan, forming chitosan/gold bioconjugates (Chi/BAuNPs). Characterization of the BAuNPs and Chi/BAuNPs conjugates takes place using transmission electron microscopy (TEM), X-ray spectra, Fourier transform infrared (FT-IR) spectroscopy, and zeta potential (Z-potential). The chemical composition of S. officinalis extract was evaluated via gas chromatography/mass spectrometry (GC/MS). This study evaluated the antioxidant and antimicrobial activities of human pathogenic multidrug-resistant (MDR) and multisensitive (MS) bacterial isolates using the agar diffusion method. Chi/BAuNPs showed inhibition of the MDR strains more effectively than BAuNPs alone as compared with a positive standard antibiotic. The cytotoxicity assay revealed that the human breast adenocarcinoma cancer cells (MCF7) were more sensitive toward the toxicity of 5-Fu + BAuNPs and 5-Fu + Chi/BAuNPs composites compared to non-malignant human fibroblast cells (HFs). The study shows that BAuNPs and Chi/BAuNPs, combined with 5-FU NPs, can effectively treat cancer at concentrations where the free chemical drug (5-Fu) is ineffective, with a noted reduction in the required dosage for noticeable antitumor action.
- Open Access
- 26 June 2023
- Published by Naba'a Al-Hayat Foundation for Medical Sciences and Health Care in Journal of Contemporary Medical Sciences
- Vol. 9 (3) , 211-220
Case report: Identification of a rare homozygous missense variant in the PKLR gene reported for the first time in transfusion-dependent Saudi Patient
Red cell pyruvate kinase deficiency is one of the most common erythrocytic glycolytic pathway defects connected with congenital non-spherocytic anemia. The condition inherited as an autosomal recessive Mendelian trait is caused by mutations in the PKLR gene located on chromosome 1q21. Pyruvate kinase enzyme is crucial in the energy-producing glycolysis pathway that provides red blood cells with the primary source of energy (ATP). We report here a case of a Saudi female patient that was initially diagnosed at a few months old with beta-thalassemia major and was treated with regular blood transfusions and iron overload management. At the time of our sample collection, the patient was recently transferred to King Abdul Aziz University Hospital. Genetic testing was performed to identify the disease-contributing variant of beta-thalassemia using TaqMan genotyping of six common beta-thalassemia variants (negative results). NGS targeted HBB gene sequencing which did not reveal any related variants. MLPA was performed to rule out alpha thalassemia diagnosis. The use of whole genome sequencing revealed a rare missense variant in the PKLR gene c.1015G>A (D339N) in a homozygous state that correlates to her severe phenotype. Documenting this incident will aid medical staff in providing appropriate care to similar cases and highlights the importance of following up with the diagnosis investigation process to minimize misdiagnosis incidences.
- 26 June 2023
- Published by Naba'a Al-Hayat Foundation for Medical Sciences and Health Care in Journal of Contemporary Medical Sciences
- Vol. 9 (3) , 211-220
Open AccessCase report: Identification of a rare homozygous missense variant in the PKLR gene reported for the first time in transfusion-dependent Saudi Patient
Red cell pyruvate kinase deficiency is one of the most common erythrocytic glycolytic pathway defects connected with congenital non-spherocytic anemia. The condition inherited as an autosomal recessive Mendelian trait is caused by mutations in the PKLR gene located on chromosome 1q21. Pyruvate kinase enzyme is crucial in the energy-producing glycolysis pathway that provides red blood cells with the primary source of energy (ATP). We report here a case of a Saudi female patient that was initially diagnosed at a few months old with beta-thalassemia major and was treated with regular blood transfusions and iron overload management. At the time of our sample collection, the patient was recently transferred to King Abdul Aziz University Hospital. Genetic testing was performed to identify the disease-contributing variant of beta-thalassemia using TaqMan genotyping of six common beta-thalassemia variants (negative results). NGS targeted HBB gene sequencing which did not reveal any related variants. MLPA was performed to rule out alpha thalassemia diagnosis. The use of whole genome sequencing revealed a rare missense variant in the PKLR gene c.1015G>A (D339N) in a homozygous state that correlates to her severe phenotype. Documenting this incident will aid medical staff in providing appropriate care to similar cases and highlights the importance of following up with the diagnosis investigation process to minimize misdiagnosis incidences.
- Open Access
Integration of Chemoinformatics and Multi-Omics Analysis Defines ECT2 as a Potential Target for Cancer Drug Therapy
Epithelial cell transforming 2 (ECT2) is a potential oncogene and a number of recent studies have correlated it with the progression of several human cancers. Despite this elevated attention for ECT2 in oncology-related reports, there is no collective study to combine and integrate the expression and oncogenic behavior of ECT2 in a panel of human cancers. The current study started with a differential expression analysis of ECT2 in cancerous versus normal tissue. Following that, the study asked for the correlation between ECT2 upregulation and tumor stage, grade, and metastasis, along with its effect on patient survival. Moreover, the methylation and phosphorylation status of ECT2 in tumor versus normal tissue was assessed, in addition to the investigation of the ECT2 effect on the immune cell infiltration in the tumor microenvironment. The current study revealed that ECT2 was upregulated as mRNA and protein levels in a list of human tumors, a feature that allowed for the increased filtration of myeloid-derived suppressor cells (MDSC) and decreased the level of natural killer T (NKT) cells, which ultimately led to a poor prognosis survival. Lastly, we screened for several drugs that could inhibit ECT2 and act as antitumor agents. Collectively, this study nominated ECT2 as a prognostic and immunological biomarker, with reported inhibitors that represent potential antitumor drugs.
Open AccessIntegration of Chemoinformatics and Multi-Omics Analysis Defines ECT2 as a Potential Target for Cancer Drug Therapy
Epithelial cell transforming 2 (ECT2) is a potential oncogene and a number of recent studies have correlated it with the progression of several human cancers. Despite this elevated attention for ECT2 in oncology-related reports, there is no collective study to combine and integrate the expression and oncogenic behavior of ECT2 in a panel of human cancers. The current study started with a differential expression analysis of ECT2 in cancerous versus normal tissue. Following that, the study asked for the correlation between ECT2 upregulation and tumor stage, grade, and metastasis, along with its effect on patient survival. Moreover, the methylation and phosphorylation status of ECT2 in tumor versus normal tissue was assessed, in addition to the investigation of the ECT2 effect on the immune cell infiltration in the tumor microenvironment. The current study revealed that ECT2 was upregulated as mRNA and protein levels in a list of human tumors, a feature that allowed for the increased filtration of myeloid-derived suppressor cells (MDSC) and decreased the level of natural killer T (NKT) cells, which ultimately led to a poor prognosis survival. Lastly, we screened for several drugs that could inhibit ECT2 and act as antitumor agents. Collectively, this study nominated ECT2 as a prognostic and immunological biomarker, with reported inhibitors that represent potential antitumor drugs.
- 3 November 2022
- Published by Elsevier in Microbial Pathogenesis
- Vol. 173 (Pt A) , 105838
Study the apoptosis and necrosis inducing of fosfomycin into associated infected urothelial tissue by extended spectrum beta lactamase positive of E. coli
- 3 November 2022
- Published by Elsevier in Microbial Pathogenesis
- Vol. 173 (Pt A) , 105838
Study the apoptosis and necrosis inducing of fosfomycin into associated infected urothelial tissue by extended spectrum beta lactamase positive of E. coli